Better Health for All

Sanara MedTech's core products, such as CellerateRX Surgical Powder,

deliver exceptional health benefits. A study of 5,335 patients demonstrated a 59% reduction in surgical site infection rates overall, and a 69% reduction in clean cases. Other products contribute to a 25-40% reduction in wound healing time and 60% infection prevention. The company's products are priced at approximately 2.86 to 3.57 times their production cost, based on a 65-72% gross margin. Sanara MedTech also engages in healthcare education, having conducted 6 webinar series, providing 12 CME credits to 1,425 participants. The use of CellerateRX to significantly reduce surgical site infections is a direct preventative health measure.

Fair Pay & Worker Respect

The provided articles do not contain specific, quantitative data for any of the KPIs related to Fair Pay & Worker Respect.

explicitly lists all relevant KPIs, such as living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, and health insurance coverage, as missing. further confirms the absence of quantitative data regarding employee compensation, benefits, or treatment, and states that no regulatory actions, violations, or fines are mentioned.

Fair Trade & Ethical Sourcing

The provided articles, including an annual report, terms of use, code of ethics, and corporate governance documents, do not contain any specific, concrete data points or mentions related to fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical sourcing clauses in contracts, share of high-risk materials, or supplier diversity spend.

Therefore, no KPIs for Fair Trade & Ethical Sourcing can be scored based on the evidence provided.

Honest & Fair Business

The company has a Code of Ethics and Business Conduct that mandates compliance with anti-corruption and anti-bribery laws, including AdvaMed's Code of Conduct.

However, the policy's training frequency and effectiveness metrics are not specified. Procedures for complaints regarding accounting, internal controls, or auditing matters are established and overseen, and reporting and enforcement procedures are outlined, but specific details on whistleblower protection are not provided. Approximately 53% of the board members are free from material conflicts of interest.

Kind to Animals

Sanara MedTech Inc. uses animal-derived inputs in its products, with FORTIFY TRG® Tissue Repair Graft being 100% porcine small intestinal submucosa (SIS) ECM

and BiFORM® Bioactive Moldable Matrix containing 20% bovine Type I collagen and 50% bovine anorganic bone mineral. There is no evidence of substitution with ethical alternatives. The company conducts animal testing for medical analysis and clinical research, as evidenced by the use of 36 New Zealand white rabbits in an in vivo study for BiFORM® Bioactive Moldable Matrix. The company's website also states that new blood vessels forming in the FORTIFY TRG™ scaffold were observed in an animal model. There is no formal animal testing policy mentioned. The company used 36 New Zealand white rabbits in a single study, with no transparent reduction targets. The company's reliance on bovine and porcine components for its products indicates a direct link to animal agriculture, with no information provided on ethical practices or humane certifications.

No War, No Weapons

Sanara MedTech Inc. is a medical technology company focused on wound and skin care products.

The provided articles, including an annual report and a code of ethics, do not contain any specific, concrete data points or explicit statements from the company regarding its involvement in arms contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, conflict divestment policies, board oversight of defense activities, export certifications, lobbying related to arms control, humanitarian procurement, human rights due diligence in conflict zones, Arms Trade Treaty compliance, AI military safeguards, UN Guiding Principles alignment, dual-use item screening, surveillance contracts, ethical red lines for weapons, exposure to controversial weapons, war-risk audits, conflict partner reviews, defense divestment, conflict minerals, peace technology investment, procurement from conflict zones, or ethical red lines compliance rates. Therefore, no KPIs can be scored based on the available evidence.

Zero Waste & Sustainable Products

No specific, concrete data points for Sanara MedTech Inc. (SMTI.US) related to waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles.

The company's 2022 Form 10-K explicitly states that key metrics related to zero waste and sustainable products are not reported.